Sunshine Guojian Pharmaceutical Co., Ltd. (688336)
SSE
Closed
Sep 18, 2026
Day's Range
40.0052 wk Range
34.34Overview - 688336 - Sunshine Guojian Pharmaceutical Co., Ltd.
Key Statistics
Valuation
Enterprise Value
28.81B
P/E (Trailing)
‪11.09‬
P/E (Forward)
‪45.86‬
PEG Ratio
‪45.86‬
Price / Sales (TTM)
‪7.71‬
Price / Book
‪4.01‬
EV / EBITDA
‪8.40‬
Profitability
Gross Margin
‪80.25%‬
Profit Margin
‪69.64%‬
Operating Margin
‪29.46%‬
Return on Assets
‪27.84%‬
Return on Equity
‪43.52%‬
Ownership
Shares Outstanding
896.22M
Float
138.48M
Held by Insiders
‪84.43%‬
Held by Institutions
‪6.68%‬
Price stats
Beta
‪0.34‬
50-Day Avg
‪45.27‬
200-Day Avg
‪45.25‬
Dividends
Payout Ratio
‪13.79%‬
Frequency
Semi-Annual
Analyst Consensus
1 analysts
Market Cap - 688336 - Sunshine Guojian Pharmaceutical Co., Ltd.
Peers - 688336 - Sunshine Guojian Pharmaceutical Co., Ltd.
Peer Comparison
Compared with companies in Biotechnology listed on SSE.
Profile Summary - 688336 - Sunshine Guojian Pharmaceutical Co., Ltd.
About
Sunshine Guojian Pharmaceutical Co., Ltd. is a biopharmaceutical company specializing in the research, development, and manufacture of innovative therapeutic drugs, with a strong emphasis on monoclonal antibodies. As a key player in the biotechnology sector, Sunshine Guojian integrates advanced technology platforms…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
